These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 32793662)

  • 1. A scientificity and feasibility evaluation of COVID-19 clinical studies registered in China.
    Tao L; Zhang H; Zhuo L; Liu Y; Qiao R; Zhao Y; Zhan S
    Ann Transl Med; 2020 Jul; 8(13):817. PubMed ID: 32793662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiencies in Planning Interventional Trial Registration of COVID-19 in China.
    Li X; Zhang S; Zhou Y; Liu Y; Zhou Y; Li S; Su N
    Front Med (Lausanne); 2021; 8():618185. PubMed ID: 33869242
    [No Abstract]   [Full Text] [Related]  

  • 3. Research Collaboration and Outcome Measures of Interventional Clinical Trial Protocols for COVID-19 in China.
    Gao Y; Yang K; Liu M; Chen Y; Shi S; Yang F; Tian J
    Front Public Health; 2020; 8():554247. PubMed ID: 32984256
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): A systematic review.
    Yang M; Shang YX; Tian ZY; Xiong M; Lu CL; Jiang Y; Zhang Y; Zhang YY; Jin XY; Jin QB; Zhang Y; Willcox ML; Liu JP
    Integr Med Res; 2020 Sep; 9(3):100426. PubMed ID: 32483523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status quo, issues, and challenges for acupuncture research evidence: an overview of clinical and fundamental studies.
    Cai Y; Shen J; Zhong D; Li Y; Wu T
    J Evid Based Med; 2012 Feb; 5(1):12-24. PubMed ID: 23528116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-related research in Africa: a cross-sectional review of the International Clinical Trial Registration Platform (ICTRP).
    Edem B; Williams V; Onwuchekwa C; Umesi A; Calnan M
    Trials; 2021 Oct; 22(1):682. PubMed ID: 34620207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.
    Manoharan L; Olliaro P; Horby PW; Watson CH
    Trials; 2021 May; 22(1):370. PubMed ID: 34051840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies registered in non-ClinicalTrials.gov accounted for an increasing proportion of protocol registrations in medical research.
    Banno M; Tsujimoto Y; Kataoka Y
    J Clin Epidemiol; 2019 Dec; 116():106-113. PubMed ID: 31521723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the registration of clinical trials in UMIN-CTR from 2 June 2005 to 1 June 2010 - focus on Japan domestic, academic clinical trials.
    Tang W; Fukuzawa M; Ishikawa H; Tsutani K; Kiuchi T
    Trials; 2013 Oct; 14():333. PubMed ID: 24124926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and trends of clinical studies primarily sponsored by China in WHO primary registries between 2009 and 2018: a cross-sectional survey.
    Xu Y; Dong M; Liu X
    BMJ Open; 2020 Nov; 10(11):e037262. PubMed ID: 33444176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.
    Ma LL; Yin X; Li BH; Yang JY; Jin YH; Huang D; Deng T; Wang YY; Ren XQ; Ji J; Zeng XT
    Front Pharmacol; 2020; 11():540187. PubMed ID: 32982751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
    Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
    BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.
    Villanustre F; Chala A; Dev R; Xu L; LexisNexis JS; Furht B; Khoshgoftaar T
    J Big Data; 2021; 8(1):33. PubMed ID: 33614394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
    Yotsu RR; Richardson M; Ishii N
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012118. PubMed ID: 30136733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.